As a leading global healthcare and diagnostics company, Hologic strives to make advances toward greater certainty for customers by providing them with cutting-edge technology, such as the Aptima and ThinPrep products, that makes a real difference. Hologic’s Diagnostic Solutions division moves to narrow the gap between doubt and confidence and works to achieve both incremental and transformational progress to improve patients’ lives.

The Aptima Women’s Health assays detect RNA for optimal performance on the Panther system to safeguard women’s health today and in the future. The Aptima Women’s Health assays diagnose STIs and HPV with precision so healthcare professionals can intervene and protect.

The ThinPrep® Pap test was the first liquid-based cytology option in cervical cancer screening.¹ In more than 2 decades, the ThinPrep Pap test has contributed to a serious decline in cervical cancer rates. ^{1, 2}